0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538
Hepatitis A - Epidemiology Forecast to 2028
Published Date: April 2019
|
Report Code: DELV-Epid-224
Home | Category |Health |Health Conditions |Infectious Diseases
Hepatitis A  Epidemiology Forecast to 2028

Hepatitis A - Epidemiology Forecast to 2028

Code: DELV-Epid-224
Report
April 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Hepatitis A - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hepatitis A epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hepatitis A Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hepatitis A in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hepatitis A outlook. It also includes the explanation of changing trends of epidemiology outlining the Hepatitis A scenario.

Hepatitis A Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hepatitis A thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hepatitis A explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hepatitis A Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hepatitis A

Key assessments
• Patient Segmentation in Hepatitis A
• Hepatitis A Risk & Burden
• Factors driving growth in a specific Hepatitis A patient population

1. Report Introduction
2. Hepatitis A Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hepatitis A in 2016
2.2. Patient Share Distribution of Hepatitis A in 2028
3. Disease Background and Overview: Hepatitis A
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM – By Countries
5. Epidemiology of Hepatitis A by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hepatitis A
5.1.3. Sub-Type Specific cases of the Hepatitis A *
5.1.4. Sex- Specific Cases of the Hepatitis A *
5.1.5. Diagnosed Cases of the Hepatitis A
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hepatitis A
5.4.3. Sub-Type Specific cases of the Hepatitis A *
5.4.4. Sex- Specific Cases of the Hepatitis A *
5.4.5. Diagnosed Cases of the Hepatitis A
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hepatitis A
5.5.3. Sub-Type Specific cases of the Hepatitis A *
5.5.4. Sex- Specific Cases of the Hepatitis A *
5.5.5. Diagnosed Cases of the Hepatitis A
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hepatitis A
5.6.3. Sub-Type Specific cases of the Hepatitis A *
5.6.4. Sex- Specific Cases of the Hepatitis A *
5.6.5. Diagnosed Cases of the Hepatitis A
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hepatitis A
5.7.3. Sub-Type Specific cases of the Hepatitis A *
5.7.4. Sex- Specific Cases of the Hepatitis A *
5.7.5. Diagnosed Cases of the Hepatitis A
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hepatitis A
5.8.3. Sub-Type Specific cases of the Hepatitis A *
5.8.4. Sex- Specific Cases of the Hepatitis A *
5.8.5. Diagnosed Cases of the Hepatitis A
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hepatitis A
5.9.3. Sub-Type Specific cases of the Hepatitis A *
5.9.4. Sex- Specific Cases of the Hepatitis A *
5.9.5. Diagnosed Cases of the Hepatitis A
6. Unmet Needs of the Hepatitis A
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables :


Table 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Table 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

DelveInsight's "Hepatitis A - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Hepatitis A epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Hepatitis A Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Hepatitis A in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Hepatitis A outlook. It also includes the explanation of changing trends of epidemiology outlining the Hepatitis A scenario.

Hepatitis A Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Hepatitis A thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Hepatitis A explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Hepatitis A Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Hepatitis A

Key assessments
• Patient Segmentation in Hepatitis A
• Hepatitis A Risk & Burden
• Factors driving growth in a specific Hepatitis A patient population

Read More

1. Report Introduction
2. Hepatitis A Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Hepatitis A in 2016
2.2. Patient Share Distribution of Hepatitis A in 2028
3. Disease Background and Overview: Hepatitis A
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM
4.3. Total Prevalent/ Incident Patient Population of Hepatitis A in 7MM – By Countries
5. Epidemiology of Hepatitis A by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Hepatitis A
5.1.3. Sub-Type Specific cases of the Hepatitis A *
5.1.4. Sex- Specific Cases of the Hepatitis A *
5.1.5. Diagnosed Cases of the Hepatitis A
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Hepatitis A
5.4.3. Sub-Type Specific cases of the Hepatitis A *
5.4.4. Sex- Specific Cases of the Hepatitis A *
5.4.5. Diagnosed Cases of the Hepatitis A
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Hepatitis A
5.5.3. Sub-Type Specific cases of the Hepatitis A *
5.5.4. Sex- Specific Cases of the Hepatitis A *
5.5.5. Diagnosed Cases of the Hepatitis A
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Hepatitis A
5.6.3. Sub-Type Specific cases of the Hepatitis A *
5.6.4. Sex- Specific Cases of the Hepatitis A *
5.6.5. Diagnosed Cases of the Hepatitis A
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Hepatitis A
5.7.3. Sub-Type Specific cases of the Hepatitis A *
5.7.4. Sex- Specific Cases of the Hepatitis A *
5.7.5. Diagnosed Cases of the Hepatitis A
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Hepatitis A
5.8.3. Sub-Type Specific cases of the Hepatitis A *
5.8.4. Sex- Specific Cases of the Hepatitis A *
5.8.5. Diagnosed Cases of the Hepatitis A
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Hepatitis A
5.9.3. Sub-Type Specific cases of the Hepatitis A *
5.9.4. Sex- Specific Cases of the Hepatitis A *
5.9.5. Diagnosed Cases of the Hepatitis A
6. Unmet Needs of the Hepatitis A
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

List of Tables :


Table 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Table 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Table 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Table 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Table 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Table 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Table 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

List of Figures :

Figure 1: Total Prevalent/Incident Cases of the Hepatitis A in 7MM
Figure 2: Total Prevalent/Incident Cases of the Hepatitis A in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Hepatitis A in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Hepatitis A in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Hepatitis A in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Hepatitis A in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Hepatitis A in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Hepatitis A in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Hepatitis A in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Hepatitis A in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Hepatitis A in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Hepatitis A in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Hepatitis A in France (2016-2028) *
Figure 14: Diagnosed Cases of the Hepatitis A in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Hepatitis A in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Hepatitis A in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Hepatitis A in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Hepatitis A in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Hepatitis A in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Hepatitis A in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Hepatitis A in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Hepatitis A in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Hepatitis A in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Hepatitis A in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Hepatitis A in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Hepatitis A in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Hepatitis A in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Hepatitis A in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Hepatitis A in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Hepatitis A in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

Global Typhoid Fever Vaccines Market Research Report 2020
Global Typhoid Fever Vaccines Market Research Report 2020

million US by the end of growing at a CAGR of .

120 Pages
Type: Report
Code: QYRE-Auto-23J780
Fri Jan 17 00:00:00 UTC 2020

Add to Cart

Global Diphtheria Vaccines Market Research Report 2020
Global Diphtheria Vaccines Market Research Report 2020

The global Diphtheria Vaccines market is valued at xx million US in is expected to reach xx million US by the end of growing at a CAGR of xx during .This report focuses on Diphtheria Vaccines volume and value at the global level regional level and company level.

120 Pages
Type: Report
Code: QYRE-Auto-19D944
Fri Jan 17 00:00:00 UTC 2020

Add to Cart

Global Japanese Encephalitis Vaccines Market Research Report 2020
Global Japanese Encephalitis Vaccines Market Research Report 2020

The global Japanese Encephalitis Vaccines market is valued at xx million US in is expected to reach xx million US by the end of growing at a CAGR of xx during .This report focuses on Japanese Encephalitis Vaccines volume and value at the global level regional level and company level.

120 Pages
Type: Report
Code: QYRE-Auto-30A787
Fri Jan 17 00:00:00 UTC 2020

Add to Cart

Global Therapeutic BCG Vaccines Market Research Report 2020
Global Therapeutic BCG Vaccines Market Research Report 2020

The global Therapeutic BCG Vaccines market is valued at xx million US in is expected to reach xx million US by the end of growing at a CAGR of xx during .This report focuses on Therapeutic BCG Vaccines volume and value at the global level regional level and company level.

120 Pages
Type: Report
Code: QYRE-Auto-31B795
Fri Jan 17 00:00:00 UTC 2020

Add to Cart

0 Items
X
No items in the cart.
$0.0